A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B (CHB).

NCT00435825 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

551

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: peginterferon alfa-2a [Pegasys]

Sponsor

Hoffmann-La Roche